Michael Trettel
Examiner (ID: 14974)
Most Active Art Unit | 3673 |
Art Unit(s) | 3505, 3633, 3508, 3673, 3627, 3628 |
Total Applications | 3400 |
Issued Applications | 2895 |
Pending Applications | 103 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16933771
[patent_doc_number] => 20210199660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => BIOMARKERS OF BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/100106
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100106 | BIOMARKERS OF BREAST CANCER | Nov 19, 2020 | Pending |
Array
(
[id] => 16629019
[patent_doc_number] => 20210047672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHODS FOR DIAGNOSING BACTERIAL VAGINOSIS
[patent_app_type] => utility
[patent_app_number] => 17/079617
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079617 | Methods for diagnosing bacterial vaginosis | Oct 25, 2020 | Issued |
Array
(
[id] => 16992252
[patent_doc_number] => 20210230672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD FOR THE DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
[patent_app_type] => utility
[patent_app_number] => 17/067524
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067524 | METHOD FOR THE DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS | Oct 8, 2020 | Abandoned |
Array
(
[id] => 16886758
[patent_doc_number] => 20210172954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/035318
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/035318 | DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER | Sep 27, 2020 | Abandoned |
Array
(
[id] => 16720491
[patent_doc_number] => 20210087638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => NEXT-GENERATION SEQUENCING ASSAY FOR GENOMIC CHARACTERIZATION AND MINIMAL RESIDUAL DISEASE DETECTION IN THE BONE MARROW, PERIPHERAL BLOOD, AND URINE OF MULTIPLE MYELOMA AND SMOLDERING MYELOMA PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/029684
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/029684 | NEXT-GENERATION SEQUENCING ASSAY FOR GENOMIC CHARACTERIZATION AND MINIMAL RESIDUAL DISEASE DETECTION IN THE BONE MARROW, PERIPHERAL BLOOD, AND URINE OF MULTIPLE MYELOMA AND SMOLDERING MYELOMA PATIENTS | Sep 22, 2020 | Pending |
Array
(
[id] => 16557558
[patent_doc_number] => 20210002706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Methods For Determining Antimicrobial Drug Resistance
[patent_app_type] => utility
[patent_app_number] => 16/920109
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/920109 | Methods For Determining Antimicrobial Drug Resistance | Jul 1, 2020 | Pending |
Array
(
[id] => 16571081
[patent_doc_number] => 20210010087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate Cancer
[patent_app_type] => utility
[patent_app_number] => 16/902552
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902552 | Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate Cancer | Jun 15, 2020 | Pending |
Array
(
[id] => 16312738
[patent_doc_number] => 20200291476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => ASSAY FOR PRE-OPERATIVE PREDICTION OF ORGAN FUNCTION RECOVERY
[patent_app_type] => utility
[patent_app_number] => 16/888447
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888447 | Assay for pre-operative prediction of organ function recovery | May 28, 2020 | Issued |
Array
(
[id] => 16452985
[patent_doc_number] => 20200362411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => METHOD FOR PREDICTING CERVICAL SHORTENING AND PRETERM BIRTH
[patent_app_type] => utility
[patent_app_number] => 16/880766
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880766 | Method for predicting cervical shortening and preterm birth | May 20, 2020 | Issued |
Array
(
[id] => 16452995
[patent_doc_number] => 20200362421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => CLASSIFICATION AND ACTIONABILITY INDICES FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/863360
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863360 | CLASSIFICATION AND ACTIONABILITY INDICES FOR CANCER | Apr 29, 2020 | Pending |
Array
(
[id] => 16361450
[patent_doc_number] => 20200318201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHODS OF DETECTING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/853027
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853027 | METHODS OF DETECTING PROSTATE CANCER | Apr 19, 2020 | Pending |
Array
(
[id] => 16238678
[patent_doc_number] => 20200255912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => TET2 as a Diagnostic and Pronostic Marker in Hematopoietic Neoplasms
[patent_app_type] => utility
[patent_app_number] => 16/843507
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843507 | TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms | Apr 7, 2020 | Issued |
Array
(
[id] => 16361449
[patent_doc_number] => 20200318200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Methods for Identifying Progression of a Primary Melanoma
[patent_app_type] => utility
[patent_app_number] => 16/838926
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838926
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/838926 | Methods for Identifying Progression of a Primary Melanoma | Apr 1, 2020 | Abandoned |
Array
(
[id] => 16073231
[patent_doc_number] => 20200190602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY
[patent_app_type] => utility
[patent_app_number] => 16/799797
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799797 | METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY | Feb 23, 2020 | Pending |
Array
(
[id] => 16013717
[patent_doc_number] => 20200181701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING ALLOGENEIC MATTER IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 16/795371
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795371
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795371 | Compositions and methods for detecting allogeneic matter in a subject | Feb 18, 2020 | Issued |
Array
(
[id] => 18545534
[patent_doc_number] => 11718875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Compositions and methods for detecting allogeneic matter in a subject
[patent_app_type] => utility
[patent_app_number] => 16/795375
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7044
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795375 | Compositions and methods for detecting allogeneic matter in a subject | Feb 18, 2020 | Issued |
Array
(
[id] => 18478484
[patent_doc_number] => 11692216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Method for assisting prediction of risk of occurrence of side effect of irinotecan
[patent_app_type] => utility
[patent_app_number] => 16/788406
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9179
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788406 | Method for assisting prediction of risk of occurrence of side effect of irinotecan | Feb 11, 2020 | Issued |
Array
(
[id] => 16223156
[patent_doc_number] => 20200248272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => COMPOSITIONS AND METHODS FOR ISOLATING CELL-FREE DNA
[patent_app_type] => utility
[patent_app_number] => 16/778572
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/778572 | Compositions and methods for isolating cell-free DNA | Jan 30, 2020 | Issued |
Array
(
[id] => 16328810
[patent_doc_number] => 20200299776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => SOLID TUMOR METHYLATION MARKERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/727843
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16727843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/727843 | SOLID TUMOR METHYLATION MARKERS AND USES THEREOF | Dec 25, 2019 | Abandoned |
Array
(
[id] => 17792564
[patent_doc_number] => 20220251655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => MITOCHONDRIAL DNA DELETIONS ASSOCIATED WITH ENDOMETRIOSIS
[patent_app_type] => utility
[patent_app_number] => 17/415507
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415507 | MITOCHONDRIAL DNA DELETIONS ASSOCIATED WITH ENDOMETRIOSIS | Dec 19, 2019 | Pending |